CAROLINE HARVEY: Open Payments
NPI 1730279886 · SPARKS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 63 payments from 16 companies in 2025. Trend: 2023 $65 · 2024 $734 · 2025 $1,493
Food & beverage: $1,493
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $218 |
| GENZYME CORPORATION | 7 | $193 |
| Arcutis Biotherapeutics, Inc. | 1 | $151 |
| UCB, Inc. | 6 | $145 |
| Janssen Biotech, Inc. | 4 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| LEO Pharma Inc. | 3 | $79 |
| Galderma Laboratories, L.P. | 4 | $75 |
| Lilly USA, LLC | 3 | $66 |
Products named: DUPIXENT, Zoryve, Bimzelx, TREMFYA, SKYRIZI, RINVOQ, TALTZ, ILUMYA.
Industry payments across MD — which companies pay providers there.
